氨苯蝶啶肾结石：值得重新关注。

Triamterene nephrolithiasis: renewed attention is warranted.

作者信息

Carr M C, Prien E L, Babayan R K

机构信息

Department of Urology, Boston University Medical Center, Massachusetts.

出版信息

J Urol. 1990 Dec;144(6):1339-40. doi: 10.1016/s0022-5347(17)39734-3.

DOI:10.1016/s0022-5347(17)39734-3

PMID:2231920

Abstract

Although triamterene has been known to contribute to urinary calculus formation, it has been presumed to be a rare phenomenon. Our review of stone analyses performed during the last decade by a single laboratory reveals an increasing incidence of triamterene stones. Awareness of the calculogenic potential of triamterene-containing medications should be re-emphasized.

摘要

尽管已知氨苯蝶啶会导致尿路结石形成，但一般认为这是一种罕见现象。我们对一家实验室在过去十年中进行的结石分析回顾显示，氨苯蝶啶结石的发病率在上升。应再次强调对含氨苯蝶啶药物致结石可能性的认识。